A PROSPECTIVE STUDY OF ANTI-HCV POSITIVE BLOOD DONORS
A PROSPECTIVE STUDY OF ANTI-HCV POSITIVE BLOOD DONORS
批准号:
2571375
负责人:
H J ALTER
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
antiviral antibody blood donor chronic disease /disorder clinical research cocaine communicable disease transmission disease /disorder proneness /risk epidemiology hepatitis C hepatitis C virus histopathology human subject intravenous drug abuse liver disorder longitudinal human study mass screening sex behavior western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This protocol is designed to study the natural history and
epidemiology of hepatitis C virus (HCV) infection in an asymptomatic
blood donor population found to be anti-HCV positive at the time of
routine blood donation. Thus far, 560 subjects have been enrolled
including 305 recombinant bioimmunassay (RIBA) positives, 143 RIBA
indeterminates, and 112 RIBA negative controls. The accrued data
have been published recently (New Engl J Med 1996; 334:1691) and can
be summarized as follows: Characteristics of HCV-infected donors
compared with controls were younger, African-American, and had a
lower education level. Independently associated risk factors for HCV
were transfusion, intravenous drug use (IVDU), cocaine snorting,
sexual promiscuity, and being male with pierced ears. Although it
was anticipated that IVDU would be a risk factor, it was a major
surprise to find that 42 percent of RIBA positive volunteer blood
donors admitted to having used intravenous drugs at some point in
their lives, generally 10 or more years before the donation. Another
major surprise was the strong independent association between
cocaine snorting and HCV positivity. Shared paraphernalia for
snorting accompanied by frequent cocaine-related epistaxis may serve
as a covert vehicle for parenteral viral transmission. Eighty-six
percent of RIBA positive donors were viremic, confirming the
persistent nature of this agent. In contrast, 13 percent of subjects
appeared to have recovered from HCV infection as evidenced by
repeatedly negative polymerase chain reaction for HCV RNA and by
persistently normal alanine aminotransferase. Sixty-six percent had
biochemical evidence of liver disease, and 86 percent of those
biopsied had a severe histologic lesion despite prolonged infection
despite an association evidence of mild to moderate chronic
hepatitis. However, only 6 percent had a severe histologic lesion
despite prolonged infection. Despite an association with sexually
promiscuous practices, when we tested the direct partners of HCV-
infected individuals, we found no evidence for HCV's sexual
transmission.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SIGNIFICANCE OF ANTI-HIV ANTIBODY IN ASYMPTOMATIC DONORS
-
批准号:5201139
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
A PROSPECTIVE STUDY OF ANTI-HCV POSITIVE BLOOD DONORS
-
批准号:5201145
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
TRANSMISSION OF HTLV-III (AIDS) INFECTION TO THE CHIMPANZEE
-
批准号:4691952
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
EVALUATION AND LONG-TERM FOLLOW-UP OF HBSAG-POSITIVE BLOOD DONORS
-
批准号:3963132
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
POST-TRANSFUSION HEPATITIS (PTH) IN OPEN HEART SURGERY PATIENTS
-
批准号:3963122
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
TRANSMISSION OF HIV (AIDS) INFECTION TO THE CHIMPANZEE
-
批准号:3837955
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
A CONTROLLED PROSPECTIVE STUDY OF TRANSFUSION-ASSOCIATED HEPATITIS
-
批准号:3774453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
A PROSPECTIVE STUDY OF ANTI-HCV POSITIVE BLOOD DONORS
-
批准号:3774464
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
VIRAL AND IMMUNE FACTORS THAT INFLUENCE RECOVERY OR PROGRESSION OF HEPATITIS C
-
批准号:6161495
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
CLINICAL ASPECTS OF HEPATITIS G VIRUS INFECTION
-
批准号:2456691
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
CLINICAL ASPECTS OF HEPATITIS G VIRUS INFECTION
-
批准号:6161497
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
SAFETY AND IMMUNOGENICITY STUDIES OF A DNA RECOMBINANT HEPATITIS B VACCINE
-
批准号:3916478
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
SAFETY AND IMMUNOGENICITY STUDIES OF A DNA RECOMBINANT HEPATITIS B VACCINE
-
批准号:3874303
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
POST-TRANSFUSION HEPATITIS (PTH) IN OPEN HEART SURGERY PATIENTS
-
批准号:3939415
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
ASYMPTOMATIC BLOOD DONORS WITH ELEVATED TRANSAMINASE (ALT) LEVELS
-
批准号:3963126
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
SAFETY AND IMMUNOGENICITY STUDIES OF A DNA RECOMBINANT HEPATITIS B VACCINE
-
批准号:4691950
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
CLONING AND CHARACTERIZATION OF THE HEPATITIS G VIRUS
-
批准号:2571377
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
A CONTROLLED PROSPECTIVE STUDY OF TRANSFUSION-ASSOCIATED HEPATITIS
-
批准号:3752229
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
A PROSPECTIVE STUDY OF ANTI-HCV POSITIVE BLOOD DONORS
-
批准号:3752237
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
POST-TRANSFUSION HEPATITIS (PTH) IN OPEN HEART SURGERY PATIENTS
-
批准号:3853075
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:H J ALTER
-
依托单位:
海外基金